Arrowhead Pharmaceuticals Inc. (ARWR) Debt to Equity Ratio
Arrowhead Pharmaceuticals Inc. (ARWR) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2016-09-30 | 0.35 |
| 2017-09-30 | 0.28 |
| 2018-09-30 | 0.17 |
| 2019-09-30 | 0.43 |
| 2020-09-30 | 0.13 |
| 2021-09-30 | 0.74 |
| 2022-09-30 | 0.69 |
| 2023-09-30 | 0.77 |
| 2024-09-30 | 3.28 |
| 2025-09-30 | 1.10 |
Get Arrowhead Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("ARWR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARWR | $66.23 | +2.91% | 1.42M |
| 3 | ||||
| 4 | ||||
| 5 |